Mitigating Risk in the Business of Drug Development

For small or emerging biopharma companies, the key to business success extends well-beyond the quality of your molecule. To realize the full potential of your discovery, you need partners who can help you anticipate and overcome financial, strategic and operational challenges throughout your development journey:

Join Michel Lagarde, SVP and President of Pharma Services at Patheon, Part of Thermo Fisher Scientific, and BioNorth Texas for a round table discussion about common challenges faced by small and emerging biopharma and the strategies to overcome them.